Correlation Between Dynavax Technologies and CalciMedica, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and CalciMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and CalciMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and CalciMedica, Common Stock, you can compare the effects of market volatilities on Dynavax Technologies and CalciMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of CalciMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and CalciMedica, Common.

Diversification Opportunities for Dynavax Technologies and CalciMedica, Common

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dynavax and CalciMedica, is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and CalciMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CalciMedica, Common Stock and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with CalciMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CalciMedica, Common Stock has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and CalciMedica, Common go up and down completely randomly.

Pair Corralation between Dynavax Technologies and CalciMedica, Common

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.42 times more return on investment than CalciMedica, Common. However, Dynavax Technologies is 2.37 times less risky than CalciMedica, Common. It trades about 0.14 of its potential returns per unit of risk. CalciMedica, Common Stock is currently generating about -0.03 per unit of risk. If you would invest  1,077  in Dynavax Technologies on October 6, 2024 and sell it today you would earn a total of  217.00  from holding Dynavax Technologies or generate 20.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dynavax Technologies  vs.  CalciMedica, Common Stock

 Performance 
       Timeline  
Dynavax Technologies 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
CalciMedica, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CalciMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Dynavax Technologies and CalciMedica, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynavax Technologies and CalciMedica, Common

The main advantage of trading using opposite Dynavax Technologies and CalciMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, CalciMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CalciMedica, Common will offset losses from the drop in CalciMedica, Common's long position.
The idea behind Dynavax Technologies and CalciMedica, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope